Drawing for TEAM INTELLIGENCE

USPTO serial 97931193

TEAM INTELLIGENCE

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
POLLACK, ALISON FRIEDBERG
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with TEAM INTELLIGENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $772*

Plus Government fees of $375

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, biological preparations, and gene therapy pharmaceutical and biological products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products all for use in the treatment of genetic diseases and disordersACTIVE—
040Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagentsACTIVE—
042Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2026EX3GSOU EXTENSION 3 GRANTED—
May 5, 2026EXT3SOU EXTENSION 3 FILED—
May 5, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2025EX2GSOU EXTENSION 2 GRANTED—
Nov 5, 2025EXT2SOU EXTENSION 2 FILED—
Nov 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2025EX1GSOU EXTENSION 1 GRANTED—
May 5, 2025EXT1SOU EXTENSION 1 FILED—
May 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 7, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 6, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 6, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024DOCKASSIGNED TO EXAMINER—
Jun 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance